Published in J Inherit Metab Dis on January 01, 2005
Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice. J Inherit Metab Dis (2007) 1.06
Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies. J Bioenerg Biomembr (2011) 0.98
Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I. PLoS One (2014) 0.85
Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons. PLoS One (2013) 0.81
Induction of oxidative stress by chronic and acute glutaric acid administration to rats. Cell Mol Neurobiol (2007) 0.80
Microarray genomic profile of mitochondrial and oxidant response in manganese chloride treated PC12 cells. Neurotoxicology (2012) 0.80
Age and brain structural related effects of glutaric and 3-hydroxyglutaric acids on glutamate binding to plasma membranes during rat brain development. Cell Mol Neurobiol (2007) 0.78
Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity. J Inherit Metab Dis (2006) 0.77
Neurotoxic effects of trans-glutaconic acid in rats. Oxid Med Cell Longev (2013) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol (1990) 6.05
Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol (1992) 5.26
Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J Leukoc Biol (1990) 3.31
Nitric-oxide synthase assays. Methods Enzymol (1994) 2.19
Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol (1997) 1.90
Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet (2003) 1.69
Iron in the brain. Nutr Rev (1993) 1.58
Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med (1991) 1.28
CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR Am J Neuroradiol (1995) 1.24
Glutaric aciduria: biochemical and morphologic considerations. J Pediatr (1977) 1.23
Glutaric aciduria type I: pathomechanisms of neurodegeneration. J Inherit Metab Dis (1999) 1.14
Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem Res (1985) 1.12
Glutaric aciduria I: creatine supplementation restores creatinephosphate levels in mixed cortex cells from rat incubated with 3-hydroxyglutarate. Mol Genet Metab (2003) 1.03
Regulation of the mitochondrial ATP-synthase in health and disease. Mol Genet Metab (2003) 1.02
Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Metab Dis (1999) 1.02
Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys (2001) 1.00
Reduced glutathione and glutathione disulfide. Methods Mol Biol (1998) 0.96
Hydrogen peroxide. Ubiquitous in cell culture and in vivo? IUBMB Life (2001) 0.96
Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med (1995) 0.95
IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J Inherit Metab Dis (2001) 0.91
Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4'-epiadriamycin in mice. Tumori (1985) 0.89
Striatal degeneration and spongy myelinopathy in glutaric acidemia. J Neurol Sci (1992) 0.88
Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Res (1998) 0.85
Ca(2+) and Na(+) dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res (2002) 0.85
Glutaric aciduria type I: ultrasonographic demonstration of early signs. Pediatr Radiol (1999) 0.85
Nerve cell lesions caused by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric acidaemia I. J Inherit Metab Dis (1997) 0.83
Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res (2001) 0.82
3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis (1999) 0.81
Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. Pediatr Res (2000) 0.80
Hydrogen peroxide production by alveolar macrophages is increased and its concentration is elevated in the breath of rats exposed to hypoxia: relationship to lung lipid peroxidation. Physiol Res (2003) 0.80
3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res (2002) 0.80
Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res (2001) 0.78
Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J Neurosci Res (2002) 0.78
Neuropathology in glutaric acidaemia type 1. Acta Neuropathol (1988) 0.77
Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro. Amino Acids (2000) 0.77
Inhibition of synaptosomal [3H]glutamate uptake and [3H]glutamate binding to plasma membranes from brain of young rats by glutaric acid in vitro. J Neurol Sci (2000) 0.76
Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures. Eur J Neurosci (2001) 0.75
Analytical and numerical techniques for the evaluation of free radical damage in cultured cells using scanning laser microscopy. Cytometry (1996) 0.75
The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis (2004) 1.75
Inborn errors of metabolism. Sensitivity of screening tests in high risk patients. Clin Pediatr (Phila) (1989) 1.38
Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis (2008) 1.13
Effect of sex, age, body weight, and smoking on plasma viscosity. Klin Wochenschr (1986) 1.11
Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice. J Inherit Metab Dis (2007) 1.06
Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr (1997) 0.99
Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem Int (2002) 0.92
Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta (2004) 0.92
Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int (2001) 0.92
Evidences that maternal swimming exercise improves antioxidant defenses and induces mitochondrial biogenesis in the brain of young Wistar rats. Neuroscience (2013) 0.86
Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta (2005) 0.85
Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Res (1998) 0.85
Propionic and L-methylmalonic acids induce oxidative stress in brain of young rats. Neuroreport (2000) 0.85
Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol (2010) 0.85
Effect of chemically induced propionic acidemia on neurobehavioral development of rats. Pharmacol Biochem Behav (1999) 0.84
Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid. Neurochem Int (2004) 0.84
3-hydroxyglutaric acid enhances glutamate uptake into astrocytes from cerebral cortex of young rats. Neurochem Int (2004) 0.83
Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction. Thromb Res (1991) 0.83
Effects of methylmalonic and propionic acids on glutamate uptake by synaptosomes and synaptic vesicles and on glutamate release by synaptosomes from cerebral cortex of rats. Brain Res (2001) 0.82
Detection of metabolic disorders in high-risk patients. A pilot study in Salvador, Bahia. Arq Neuropsiquiatr (1997) 0.82
Inhibition of in vitro CO2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain. Braz J Med Biol Res (2001) 0.82
Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms. Brain Res (1996) 0.82
Na+, K+ ATPase activity is markedly reduced by cis-4-decenoic acid in synaptic plasma membranes from cerebral cortex of rats. Exp Neurol (2005) 0.82
[Application of a clinical and laboratory protocol for the investigation of inborn errors of metabolism among critically ill children] J Pediatr (Rio J) (2003) 0.82
Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res (2001) 0.82
Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats. J Inherit Metab Dis (1993) 0.81
Methylmalonate administration decreases Na+,K+-ATPase activity in cerebral cortex of rats. Neuroreport (2000) 0.81
In vitro inhibition of Na+,K(+)-ATPase activity from rat cerebral cortex by guanidino compounds accumulating in hyperargininemia. Brain Res (1999) 0.81
Inhibition of rat brain Na+, K+-ATPase activity induced by homocysteine is probably mediated by oxidative stress. Neurochem Res (2001) 0.81
Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci (2000) 0.81
Alanine reverses the inhibitory effect of phenylalanine and its metabolites on Na+,K(+)-ATPase in synaptic plasma membranes from cerebral cortex of rats. Biochem Soc Trans (1995) 0.80
D-2-hydroxyglutaric acid inhibits creatine kinase activity from cardiac and skeletal muscle of young rats. Eur J Clin Invest (2003) 0.80
Effect of hyperprolinemia on acetylcholinesterase and butyrylcholinesterase activities in rat. Amino Acids (2005) 0.80
[Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage]. Acta Med Austriaca (1991) 0.80
Neurochemical effects of L-pyroglutamic acid. Neurochem Res (1995) 0.80
Inhibition of mitogen and allogeneic stimulated lymphocyte growth by human amniotic fluid: lack of correlation between alpha-fetoprotein level and in vitro immunosuppression. Eur J Obstet Gynecol Reprod Biol (1986) 0.80
3-Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats. Neuroscience (2005) 0.80
[Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study]. Dtsch Med Wochenschr (1987) 0.80
Animal models for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 0.79
Inhibition of energy metabolism by 2-methylacetoacetate and 2-methyl-3-hydroxybutyrate in cerebral cortex of developing rats. J Inherit Metab Dis (2005) 0.79
Improved therapeutic safety of oral anticoagulant therapy in Germany: the Saarland model. Semin Thromb Hemost (1999) 0.79
Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain. Neuroreport (2000) 0.79
Reduced locomotor activity of rats made histidinemic by injection of histidine. J Nutr (1989) 0.79
L-pyroglutamic acid inhibits energy production and lipid synthesis in cerebral cortex of young rats in vitro. Neurochem Res (2001) 0.79
Nitric oxide synthase inhibition by L-NAME prevents the decrease of Na+,K+-ATPase activity in midbrain of rats subjected to arginine administration. Neurochem Res (2001) 0.79
Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats. Metab Brain Dis (2000) 0.79
Hematocrit as a risk factor for vascular disease. Klin Wochenschr (1986) 0.79
Ascorbic acid and alpha-tocopherol attenuate methylmalonic acid-induced convulsions. Neuroreport (1999) 0.79
Inhibition of lymphocyte transformation by serum from pregnant women: lack of correlation with levels of alpha-fetoprotein. Biol Neonate (1983) 0.78
In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia. Brain Res (2001) 0.78
Effects of methylmalonate and propionate on uptake of glucose and ketone bodies in vitro by brain of developing rats. Biochem Med Metab Biol (1991) 0.78
Seven-year experience of a reference laboratory for detection of inborn errors of metabolism in Brazil. J Inherit Metab Dis (1991) 0.78
Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res (2001) 0.78
The influence of amino acids on mitogen-activated proliferation of human lymphocytes in vitro. Int J Immunopharmacol (1994) 0.78
Inhibition of in-vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J Pharm Pharmacol (1995) 0.78
Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate. Neuroscience (2003) 0.77
Inhibition of citrate oxidation in vitro by 2-hydroxybutyrate and 4-hydroxybutyrate in cerebral cortex of young rats. Biochem Soc Trans (1995) 0.77
Redox homeostasis is compromised in vivo by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in rat cerebral cortex and liver. Free Radic Res (2013) 0.77
Oxidative stress in phenylketonuric patients. Mol Genet Metab (2011) 0.77
The influence of organic acids on the proliferation of human peripheral lymphocytes activated by concanavalin A and pokeweed mitogen. Int J Immunopharmacol (1996) 0.77
Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyric acid. Metab Brain Dis (1999) 0.77
Platelet Na+, K+-ATPase activity as a possible peripheral marker for the neurotoxic effects of phenylalanine in phenylketonuria. Metab Brain Dis (2000) 0.77
Effects of histidine and imidazolelactic acid on various parameters of the oxidative stress in cerebral cortex of young rats. Int J Dev Neurosci (2004) 0.76
Isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency in a child with metabolic stroke. J Inherit Metab Dis (2006) 0.76
Inhibition of synaptosomal [3H]glutamate uptake and [3H]glutamate binding to plasma membranes from brain of young rats by glutaric acid in vitro. J Neurol Sci (2000) 0.76
Clinical and biochemical effects of long-term vitamin A administration to a patient with Hurler-Scheie compound. Braz J Med Biol Res (1984) 0.76
Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises. Arch Dis Child (1999) 0.76
2-Hydroxybutyrate and 4-hydroxybutyrate inhibit CO2 formation from labeled substrates by rat cerebral cortex. Biochem Soc Trans (1995) 0.76
Inhibition of Na+,K+-ATPase from rat brain cortex by propionic acid. Neuroreport (1998) 0.76
Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis (2006) 0.76
Chronic early leucine administration induces behavioral deficits in rats. Life Sci (1999) 0.75
[Regional hyperthermic fibrinolytic perfusion]. Dtsch Med Wochenschr (1993) 0.75
Response of human peripheral blood lymphocytes in the presence of cord sera: relationship of lymphocyte transformation with number of pregnancies and levels of alpha-fetoprotein. Clin Exp Immunol (1983) 0.75